Researchers have been looking into the thought that raising HDL (the good cholesterol) levels will decrease cardiovascular events (like heart attack and stroke). But, “say it ain’t so!”… the NIH study of over 3,400 patients showed no impact on major cardiovascular events with increasing HDL.
One speaker stated that the idea —that just because a drug does good things to the lipid profile follows that the agent will also reduce cardiovascular risk—- has to die.
I’ll keep watching. For us physicians, these mythbusters are pretty darn riveting.